BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T, Lowe J, Mead S, Rudge P, Collinge J, Jackson GS. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 2011;377:487-93. [PMID: 21295339 DOI: 10.1016/S0140-6736(10)62308-2] [Cited by in Crossref: 153] [Cited by in F6Publishing: 157] [Article Influence: 13.9] [Reference Citation Analysis]
Number Citing Articles
1 Condello C, Merz GE, Aoyagi A, Degrado WF, Prusiner SB. Aβ and Tau Prions Causing Alzheimer’s Disease. Methods in Molecular Biology 2023. [DOI: 10.1007/978-1-0716-2655-9_16] [Reference Citation Analysis]
2 Secker T, Hervé R, Keevil C. Sensitive microscopic quantification of surface-bound prion infectivity for the assessment of surgical instrument decontamination procedures. Journal of Hospital Infection 2022. [DOI: 10.1016/j.jhin.2022.09.020] [Reference Citation Analysis]
3 Wu J, Chen D, Shi Q, Dong X. Protein amplification technology: New advances in human prion disease diagnosis. Biosafety and Health 2021;3:325-32. [DOI: 10.1016/j.bsheal.2021.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ritchie DL, Peden AH, Barria MA. Variant CJD: Reflections a Quarter of a Century on. Pathogens 2021;10:1413. [PMID: 34832569 DOI: 10.3390/pathogens10111413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 López-Pérez Ó, Sanz-Rubio D, Hernaiz A, Betancor M, Otero A, Castilla J, Andréoletti O, Badiola JJ, Zaragoza P, Bolea R, Toivonen JM, Martín-Burriel I. Cerebrospinal Fluid and Plasma Small Extracellular Vesicles and miRNAs as Biomarkers for Prion Diseases. Int J Mol Sci 2021;22:6822. [PMID: 34201940 DOI: 10.3390/ijms22136822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Kulichikhin KY, Fedotov SA, Rubel MS, Zalutskaya NM, Zobnina AE, Malikova OA, Neznanov NG, Chernoff YO, Rubel AA. Development of molecular tools for diagnosis of Alzheimer's disease that are based on detection of amyloidogenic proteins. Prion 2021;15:56-69. [PMID: 33910450 DOI: 10.1080/19336896.2021.1917289] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Concha-Marambio L, Chacon MA, Soto C. Preclinical Detection of Prions in Blood of Nonhuman Primates Infected with Variant Creutzfeldt-Jakob Disease. Emerg Infect Dis 2020;26:34-43. [PMID: 31855141 DOI: 10.3201/eid2601.181423] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
8 Moudjou M, Castille J, Passet B, Herzog L, Reine F, Vilotte JL, Rezaei H, Béringue V, Igel-Egalon A. Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical Instruments. Front Bioeng Biotechnol 2020;8:591024. [PMID: 33335894 DOI: 10.3389/fbioe.2020.591024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Verheggen ICM, de Jong JJA, van Boxtel MPJ, Postma AA, Verhey FRJ, Jansen JFA, Backes WH. Permeability of the windows of the brain: feasibility of dynamic contrast-enhanced MRI of the circumventricular organs. Fluids Barriers CNS 2020;17:66. [PMID: 33115484 DOI: 10.1186/s12987-020-00228-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Ascari LM, Rocha SC, Gonçalves PB, Vieira TCRG, Cordeiro Y. Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies. Front Bioeng Biotechnol 2020;8:585896. [PMID: 33195151 DOI: 10.3389/fbioe.2020.585896] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
11 Knight R. Clinical diagnosis of human prion disease. Prog Mol Biol Transl Sci 2020;175:1-18. [PMID: 32958229 DOI: 10.1016/bs.pmbts.2020.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Aoyagi A, Condello C, Stöhr J, Yue W, Rivera BM, Lee JC, Woerman AL, Halliday G, van Duinen S, Ingelsson M, Lannfelt L, Graff C, Bird TD, Keene CD, Seeley WW, DeGrado WF, Prusiner SB. Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain. Sci Transl Med 2019;11:eaat8462. [PMID: 31043574 DOI: 10.1126/scitranslmed.aat8462] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 34.5] [Reference Citation Analysis]
13 Eraña H, Charco JM, González-Miranda E, García-Martínez S, López-Moreno R, Pérez-Castro MA, Díaz-Domínguez CM, García-Salvador A, Castilla J. Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases. Biomolecules 2020;10:E469. [PMID: 32204429 DOI: 10.3390/biom10030469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 Giaccone G, Moda F. PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease. Biomolecules 2020;10:E405. [PMID: 32151109 DOI: 10.3390/biom10030405] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
15 Viral CNS Infections. Hunter's Tropical Medicine and Emerging Infectious Diseases 2020. [DOI: 10.1016/b978-0-323-55512-8.00038-7] [Reference Citation Analysis]
16 Hornemann S, Schwarz P, Rushing EJ, Connolly MD, Zuckermann RN, Yam AY, Aguzzi A. Enhanced detection of prion infectivity from blood by preanalytical enrichment with peptoid-conjugated beads. PLoS One 2019;14:e0216013. [PMID: 31513666 DOI: 10.1371/journal.pone.0216013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Bougard D, Bélondrade M, Mayran C, Bruyère-Ostells L, Lehmann S, Fournier-Wirth C, Knight RS, Will RG, Green AJE. Diagnosis of Methionine/Valine Variant Creutzfeldt-Jakob Disease by Protein Misfolding Cyclic Amplification. Emerg Infect Dis 2018;24:1364-6. [PMID: 29912702 DOI: 10.3201/eid2407.172105] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
18 van de Ven NS, Vera J, Jones JR, Vundavalli S, Ridha BH. Sporadic CJD in association with HIV. J Neurol 2019;266:253-7. [PMID: 30446965 DOI: 10.1007/s00415-018-9116-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Hu Y. Molecular Techniques for Blood and Blood Product Screening. Advanced Techniques in Diagnostic Microbiology 2018. [DOI: 10.1007/978-3-319-95111-9_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Douet JY, Lacroux C, Aron N, Head MW, Lugan S, Tillier C, Huor A, Cassard H, Arnold M, Beringue V, Ironside JW, Andréoletti O. Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients. Emerg Infect Dis 2017;23:946-56. [PMID: 28518033 DOI: 10.3201/eid2306.161734] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
21 Willyard C. Screening: In the blood. Nature 2017;549:S19-21. [PMID: 28953860 DOI: 10.1038/549S19a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
22 Charco JM, Eraña H, Venegas V, García-Martínez S, López-Moreno R, González-Miranda E, Pérez-Castro MÁ, Castilla J. Recombinant PrP and Its Contribution to Research on Transmissible Spongiform Encephalopathies. Pathogens 2017;6:E67. [PMID: 29240682 DOI: 10.3390/pathogens6040067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Rudge P, Hyare H, Green A, Collinge J, Mead S. Imaging and CSF analyses effectively distinguish CJD from its mimics. J Neurol Neurosurg Psychiatry 2018;89:461-6. [PMID: 29142140 DOI: 10.1136/jnnp-2017-316853] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 11.0] [Reference Citation Analysis]
24 Wilson K, Atkinson KM, Fergusson DA, Brown A, Forster A, Murphy MSQ, Tinmouth AT, Keelan J. Problems with precaution: the transfusion medicine experience. J Risk Res 2018;2017:1-13. [PMID: 29348731 DOI: 10.1080/13669877.2017.1351478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
25 Luk C, Jones S, Thomas C, Fox NC, Mok TH, Mead S, Collinge J, Jackson GS. Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine. JAMA Neurol 2016;73:1454-60. [PMID: 27699415 DOI: 10.1001/jamaneurol.2016.3733] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
26 Will RG, Ironside JW. Sporadic and Infectious Human Prion Diseases. Cold Spring Harb Perspect Med 2017;7:a024364. [PMID: 27793965 DOI: 10.1101/cshperspect.a024364] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
27 Notari S, Yuan J, Cali I, Kong Q, Zou W. Variant Creutzfeldt-Jakob Disease☆. Reference Module in Neuroscience and Biobehavioral Psychology 2017. [DOI: 10.1016/b978-0-12-809324-5.00855-5] [Reference Citation Analysis]
28 Knight R. Clinical Features and Diagnosis of Human Prion Diseases. Neuromethods 2017. [DOI: 10.1007/978-1-4939-7211-1_4] [Reference Citation Analysis]
29 Mead S, Collinge J, Tabrizi SJ. Transmissible Spongiform Encephalopathies of Humans and Animals. Infectious Diseases 2017. [DOI: 10.1016/b978-0-7020-6285-8.00023-x] [Reference Citation Analysis]
30 Welch T, Pasternak J. Recent Advances in Neuroanesthesiology. Essentials of Neuroanesthesia 2017. [DOI: 10.1016/b978-0-12-805299-0.00056-7] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
31 Collinge J. Mammalian prions and their wider relevance in neurodegenerative diseases. Nature 2016;539:217-26. [PMID: 27830781 DOI: 10.1038/nature20415] [Cited by in Crossref: 151] [Cited by in F6Publishing: 156] [Article Influence: 25.2] [Reference Citation Analysis]
32 Talan J. An Assay Detects Sporadic Creutzfeldt-Jakob Disease in Urine. Neurology Today 2016;16:1,4-5. [DOI: 10.1097/01.nt.0000510769.18849.83] [Reference Citation Analysis]
33 Franko E, Wehner T, Joly O, Lowe J, Porter MC, Kenny J, Thompson A, Rudge P, Collinge J, Mead S. Quantitative EEG parameters correlate with the progression of human prion diseases. J Neurol Neurosurg Psychiatry 2016;87:1061-7. [PMID: 27413165 DOI: 10.1136/jnnp-2016-313501] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
34 Denkers ND, Henderson DM, Mathiason CK, Hoover EA. Enhanced prion detection in biological samples by magnetic particle extraction and real-time quaking-induced conversion. J Gen Virol 2016;97:2023-9. [PMID: 27233771 DOI: 10.1099/jgv.0.000515] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
35 Zanusso G, Monaco S, Pocchiari M, Caughey B. Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease. Nat Rev Neurol 2016;12:325-33. [PMID: 27174240 DOI: 10.1038/nrneurol.2016.65] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 13.7] [Reference Citation Analysis]
36 Zheng W, van den Hurk R, Cao Y, Du R, Sun X, Wang Y, McDermott MT, Evoy S. Aryl Diazonium Chemistry for the Surface Functionalization of Glassy Biosensors. Biosensors (Basel) 2016;6:E8. [PMID: 26985910 DOI: 10.3390/bios6010008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
37 Jones DR, Delenclos M, Baine AT, DeTure M, Murray ME, Dickson DW, McLean PJ. Transmission of Soluble and Insoluble α-Synuclein to Mice. J Neuropathol Exp Neurol 2015;74:1158-69. [PMID: 26574670 DOI: 10.1097/NEN.0000000000000262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
38 Bird SM. BSEandvCJD. Wiley StatsRef: Statistics Reference Online 2016. [DOI: 10.1002/9781118445112.stat05280.pub2] [Reference Citation Analysis]
39 Maheshwari A, Fischer M, Gambetti P, Parker A, Ram A, Soto C, Concha-Marambio L, Cohen Y, Belay ED, Maddox RA, Mead S, Goodman C, Kass JS, Schonberger LB, Hussein HM. Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications. Emerg Infect Dis 2015;21:750-9. [PMID: 25897712 DOI: 10.3201/eid2105.142017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
40 Wisniewski T, Goñi F. Transmissible Spongiform Encephalopathies. Neurotropic Viral Infections 2016. [DOI: 10.1007/978-3-319-33189-8_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
41 Sawyer EB, Edgeworth JA, Thomas C, Collinge J, Jackson GS. Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion disease. Sci Rep 2015;5:17742. [PMID: 26631638 DOI: 10.1038/srep17742] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
42 Jones DR, Delenclos M, Baine AT, Deture M, Murray ME, Dickson DW, Mclean PJ. Transmission of Soluble and Insoluble α-Synuclein to Mice. J Neuropathol Exp Neurol 2015;74:1158-69. [DOI: 10.1093/jnen/74.12.1158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Elder AM, Henderson DM, Nalls AV, Hoover EA, Kincaid AE, Bartz JC, Mathiason CK. Immediate and Ongoing Detection of Prions in the Blood of Hamsters and Deer following Oral, Nasal, or Blood Inoculations. J Virol 2015;89:7421-4. [PMID: 25926635 DOI: 10.1128/JVI.00760-15] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
44 Hammond M, Wik L, Deslys JP, Comoy E, Linné T, Landegren U, Kamali-Moghaddam M. Sensitive detection of aggregated prion protein via proximity ligation. Prion 2014;8:261-5. [PMID: 25482604 DOI: 10.4161/pri.32231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
45 Di Minno G, Perno CF, Tiede A, Navarro D, Canaro M, Güertler L, Ironside JW. Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders. Blood Rev 2016;30:35-48. [PMID: 26381318 DOI: 10.1016/j.blre.2015.07.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
46 Levine DJ, Stöhr J, Falese LE, Ollesch J, Wille H, Prusiner SB, Long JR. Mechanism of scrapie prion precipitation with phosphotungstate anions. ACS Chem Biol 2015;10:1269-77. [PMID: 25695325 DOI: 10.1021/cb5006239] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
47 Ritchie DL, Peden AH, Urwin PJ, Ironside JW. Prion Diseases of Humans. eLS 2015. [DOI: 10.1002/9780470015902.a0000426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Ironside JW, Ritchie DL, Peden AH, Head MW. Human prion diseases. Neuropathology of Neurodegenerative Diseases 2014. [DOI: 10.1017/cbo9781107588660.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
49 Diack AB, Head MW, McCutcheon S, Boyle A, Knight R, Ironside JW, Manson JC, Will RG. Variant CJD. 18 years of research and surveillance. Prion 2014;8:286-95. [PMID: 25495404 DOI: 10.4161/pri.29237] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 9.0] [Reference Citation Analysis]
50 Arellano-Anaya ZE, Huor A, Leblanc P, Lehmann S, Provansal M, Raposo G, Andréoletti O, Vilette D. Prion strains are differentially released through the exosomal pathway. Cell Mol Life Sci 2015;72:1185-96. [PMID: 25227242 DOI: 10.1007/s00018-014-1735-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
51 Saá P, Yakovleva O, de Castro J, Vasilyeva I, De Paoli SH, Simak J, Cervenakova L. First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification. J Biol Chem 2014;289:29247-60. [PMID: 25157106 DOI: 10.1074/jbc.M114.589564] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
52 Halliez S, Jaumain E, Huor A, Douet JY, Lugan S, Cassard H, Lacroux C, Béringue V, Andréoletti O, Vilette D. White blood cell-based detection of asymptomatic scrapie infection by ex vivo assays. PLoS One 2014;9:e104287. [PMID: 25122456 DOI: 10.1371/journal.pone.0104287] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
53 Lacroux C, Comoy E, Moudjou M, Perret-Liaudet A, Lugan S, Litaise C, Simmons H, Jas-Duval C, Lantier I, Béringue V, Groschup M, Fichet G, Costes P, Streichenberger N, Lantier F, Deslys JP, Vilette D, Andréoletti O. Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathog 2014;10:e1004202. [PMID: 24945656 DOI: 10.1371/journal.ppat.1004202] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 10.0] [Reference Citation Analysis]
54 Shih DT, Burnouf T. Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion. N Biotechnol. 2015;32:199-211. [PMID: 24929129 DOI: 10.1016/j.nbt.2014.06.001] [Cited by in Crossref: 112] [Cited by in F6Publishing: 116] [Article Influence: 14.0] [Reference Citation Analysis]
55 Jackson GS, Burk-Rafel J, Edgeworth JA, Sicilia A, Abdilahi S, Korteweg J, Mackey J, Thomas C, Wang G, Schott JM, Mummery C, Chinnery PF, Mead S, Collinge J. Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study. JAMA Neurol 2014;71:421-8. [PMID: 24590363 DOI: 10.1001/jamaneurol.2013.6001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
56 Halliez S, Reine F, Herzog L, Jaumain E, Haïk S, Rezaei H, Vilotte JL, Laude H, Béringue V. Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay. J Virol 2014;88:8678-86. [PMID: 24850746 DOI: 10.1128/JVI.01118-14] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
57 Mead S, Wadsworth JD, Porter MC, Linehan JM, Pietkiewicz W, Jackson GS, Brandner S, Collinge J. Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein. JAMA Neurol 2014;71:340-3. [PMID: 24445428 DOI: 10.1001/jamaneurol.2013.5378] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
58 Millar CM. vCJD and Hemophilia. Textbook of Hemophilia 2014. [DOI: 10.1002/9781118398258.ch39] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Chen CC, Wang YH. Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996. PLoS One 2014;9:e94020. [PMID: 24736322 DOI: 10.1371/journal.pone.0094020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
60 Jackson GS, Burk-Rafel J, Edgeworth JA, Sicilia A, Abdilahi S, Korteweg J, Mackey J, Thomas C, Wang G, Mead S, Collinge J. A highly specific blood test for vCJD. Blood 2014;123:452-3. [PMID: 24434999 DOI: 10.1182/blood-2013-11-539239] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
61 Newman PK, Todd NV, Scoones D, Mead S, Knight RS, Will RG, Ironside JW. Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate. J Neurol Neurosurg Psychiatry 2014;85:921-4. [PMID: 24554103 DOI: 10.1136/jnnp-2013-305590] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
62 Porter M, Mead S. Chorea in Prion Diseases. Chorea 2014. [DOI: 10.1007/978-1-4471-6455-5_13] [Reference Citation Analysis]
63 Rojas-marcos Í, Forero Díaz L, Ávila Polo R, Rivas Infante E, Franco Macías E. Enfermedades por priones. Meningitis, encefalitis y otras infecciones del SNC 2014. [DOI: 10.1016/b978-84-9022-484-7.00016-1] [Reference Citation Analysis]
64 Moudjou M, Sibille P, Fichet G, Reine F, Chapuis J, Herzog L, Jaumain E, Laferrière F, Richard CA, Laude H, Andréoletti O, Rezaei H, Béringue V. Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification. mBio 2013;5:e00829-13. [PMID: 24381300 DOI: 10.1128/mBio.00829-13] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
65 Samson K. Inherited Prion Disease May Manifest as Chronic Diarrhea Years Prior to Neurological Symptoms. Neurology Today 2013;13:8-10. [DOI: 10.1097/01.nt.0000441298.44544.64] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
66 Kenny J, Mead S. Prion diseases. Medicine 2013;41:686-8. [DOI: 10.1016/j.mpmed.2013.09.004] [Reference Citation Analysis]
67 Elder AM, Henderson DM, Nalls AV, Wilham JM, Caughey BW, Hoover EA, Kincaid AE, Bartz JC, Mathiason CK. In vitro detection of prionemia in TSE-infected cervids and hamsters. PLoS One 2013;8:e80203. [PMID: 24224043 DOI: 10.1371/journal.pone.0080203] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 7.6] [Reference Citation Analysis]
68 Klamroth R, Gröner A, Simon TL. Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates. Transfusion 2014;54:1406-17. [PMID: 24117799 DOI: 10.1111/trf.12423] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
69 Leunda A, Van Vaerenbergh B, Baldo A, Roels S, Herman P. Laboratory activities involving transmissible spongiform encephalopathy causing agents: risk assessment and biosafety recommendations in Belgium. Prion 2013;7:420-33. [PMID: 24055928 DOI: 10.4161/pri.26533] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
70 Sobrova P, Blazkova I, Chomoucka J, Drbohlavova J, Vaculovicova M, Kopel P, Hubalek J, Kizek R, Adam V. Quantum dots and prion proteins: is this a new challenge for neurodegenerative diseases imaging? Prion 2013;7:349-58. [PMID: 24055838 DOI: 10.4161/pri.26524] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
71 Gryspeirt A, Gubbins S. A Bayesian framework to assess the potential for controlling classical scrapie in sheep flocks using a live diagnostic test. Epidemics 2013;5:123-30. [PMID: 24021519 DOI: 10.1016/j.epidem.2013.05.001] [Reference Citation Analysis]
72 Brandel J, Haïk S. Le point sur les maladies à prions. Pratique Neurologique - FMC 2013;4:131-142. [DOI: 10.1016/j.praneu.2013.07.003] [Reference Citation Analysis]
73 Gupta A, Hirsch N. Prion diseases. Anaesthesia & Intensive Care Medicine 2013;14:407-409. [DOI: 10.1016/j.mpaic.2013.05.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
74 Properzi F, Pocchiari M. Identification of misfolded proteins in body fluids for the diagnosis of prion diseases. Int J Cell Biol 2013;2013:839329. [PMID: 24027585 DOI: 10.1155/2013/839329] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
75 Bechtel K, Geschwind MD. Ethics in prion disease. Prog Neurobiol 2013;110:29-44. [PMID: 23906487 DOI: 10.1016/j.pneurobio.2013.07.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
76 Segarra C, Bougard D, Moudjou M, Laude H, Béringue V, Coste J. Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection. PLoS One 2013;8:e69632. [PMID: 23894513 DOI: 10.1371/journal.pone.0069632] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
77 Lukan A, Vranac T, Curin Šerbec V. TSE diagnostics: recent advances in immunoassaying prions. Clin Dev Immunol 2013;2013:360604. [PMID: 23970925 DOI: 10.1155/2013/360604] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
78 Turner ML. Variant Creutzfeldt-Jakob Disease. Practical Transfusion Medicine 2013. [DOI: 10.1002/9781118520093.ch15] [Reference Citation Analysis]
79 Jackson GS, Mead S, Collinge J. Developing early diagnostics for prion diseases. Neurodegenerative Disease Management 2013;3:53-60. [DOI: 10.2217/nmt.12.76] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
80 Wisniewski T, Goñi F. Immunomodulation. Prions and Diseases 2013. [DOI: 10.1007/978-1-4614-5338-3_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
81 Knight R. Overview on Treatment of Prion Diseases and Decontamination of Prions. Prions and Diseases 2013. [DOI: 10.1007/978-1-4614-5338-3_16] [Reference Citation Analysis]
82 Hu Y. Molecular Techniques for Blood and Blood Product Screening. Advanced Techniques in Diagnostic Microbiology 2013. [DOI: 10.1007/978-1-4614-3970-7_28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
83 Wilham JM, Orrù CD, Vascellari S, Hughson AG, Caughey B. Quaking-Induced Conversion Assays for the Detection and Diagnosis of Prion Diseases. Prions and Diseases 2013. [DOI: 10.1007/978-1-4614-5338-3_14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
84 Airey TD, Cashman NR. The Tyr-Tyr-Arg Prion-Specific Epitope: Update and Context. Prions and Diseases 2013. [DOI: 10.1007/978-1-4614-5338-3_15] [Reference Citation Analysis]
85 Peden AH, Head MW, Ironside JW. Risk of Transmission of Creutzfeldt–Jakob Disease by Blood Transfusion. Prions and Diseases 2013. [DOI: 10.1007/978-1-4614-5338-3_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
86 Gregori L, Asher D, Scott D. Transmissible Spongiform Encephalopathies and Plasma Products. Production of Plasma Proteins for Therapeutic Use 2012. [DOI: 10.1002/9781118356807.ch27] [Reference Citation Analysis]
87 Wang LH, Bucelli RC, Patrick E, Rajderkar D, Alvarez Iii E, Lim MM, Debruin G, Sharma V, Dahiya S, Schmidt RE, Benzinger TS, Ward BA, Ances BM. Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease. J Neurol 2013;260:498-506. [PMID: 22968768 DOI: 10.1007/s00415-012-6664-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
88 Tamgüney G, Richt JA, Hamir AN, Greenlee JJ, Miller MW, Wolfe LL, Sirochman TM, Young AJ, Glidden DV, Johnson NL, Giles K, DeArmond SJ, Prusiner SB. Salivary prions in sheep and deer. Prion 2012;6:52-61. [PMID: 22453179 DOI: 10.4161/pri.6.1.16984] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
89 Wisniewski T, Goñi F. Could immunomodulation be used to prevent prion diseases? Expert Rev Anti Infect Ther 2012;10:307-17. [PMID: 22397565 DOI: 10.1586/eri.11.177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
90 Bannach O, Birkmann E, Reinartz E, Jaeger KE, Langeveld JP, Rohwer RG, Gregori L, Terry LA, Willbold D, Riesner D. Detection of prion protein particles in blood plasma of scrapie infected sheep. PLoS One 2012;7:e36620. [PMID: 22567169 DOI: 10.1371/journal.pone.0036620] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
91 Torres M, Cartier L, Matamala JM, Hernández N, Woehlbier U, Hetz C. Altered Prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease. PLoS One 2012;7:e36159. [PMID: 22558368 DOI: 10.1371/journal.pone.0036159] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
92 Orrù CD, Wilham JM, Vascellari S, Hughson AG, Caughey B. New generation QuIC assays for prion seeding activity. Prion 2012;6:147-52. [PMID: 22421206 DOI: 10.4161/pri.19430] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 7.9] [Reference Citation Analysis]
93 Makarava N, Savtchenko R, Alexeeva I, Rohwer RG, Baskakov IV. Fast and ultrasensitive method for quantitating prion infectivity titre. Nat Commun 2012;3:741. [PMID: 22415832 DOI: 10.1038/ncomms1730] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
94 Bissell M. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Yearbook of Pathology and Laboratory Medicine 2012;2012:308-310. [DOI: 10.1016/j.ypat.2011.08.037] [Reference Citation Analysis]
95 Bosque PJ. Prion Diseases. Goldman's Cecil Medicine 2012. [DOI: 10.1016/b978-1-4377-1604-7.00424-3] [Reference Citation Analysis]
96 Stockman J. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Yearbook of Pediatrics 2012;2012:256-257. [DOI: 10.1016/j.yped.2011.06.077] [Reference Citation Analysis]
97 Pollock G. No Lasting Stability. An Epidemiological Odyssey 2012. [DOI: 10.1007/978-94-007-3998-7_7] [Reference Citation Analysis]
98 Lacroux C, Vilette D, Fernández-Borges N, Litaise C, Lugan S, Morel N, Corbière F, Simon S, Simmons H, Costes P, Weisbecker JL, Lantier I, Lantier F, Schelcher F, Grassi J, Castilla J, Andréoletti O. Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models. J Virol 2012;86:2056-66. [PMID: 22156536 DOI: 10.1128/JVI.06532-11] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
99 Orrú CD, Caughey B. Prion seeded conversion and amplification assays. Top Curr Chem 2011;305:121-33. [PMID: 21678135 DOI: 10.1007/128_2011_184] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
100 Coulthart MB, Jansen GH, Olsen E, Godal DL, Connolly T, Choi BC, Wang Z, Cashman NR. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol 2011;11:133. [PMID: 22032272 DOI: 10.1186/1471-2377-11-133] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
101 Schneider SA, Klein C. What is the role of genetic testing in movement disorders practice? Curr Neurol Neurosci Rep 2011;11:351-61. [PMID: 21465148 DOI: 10.1007/s11910-011-0200-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
102 Ironside JW, Head MW, Will RG. Variant Creutzfeldt–Jakob Disease. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders 2011. [DOI: 10.1002/9781444341256.ch36] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
103 McCutcheon S, Alejo Blanco AR, Houston EF, de Wolf C, Tan BC, Smith A, Groschup MH, Hunter N, Hornsey VS, MacGregor IR, Prowse CV, Turner M, Manson JC. All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD. PLoS One 2011;6:e23169. [PMID: 21858015 DOI: 10.1371/journal.pone.0023169] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 5.9] [Reference Citation Analysis]
104 Wood H. Prion disease: New techniques developed for prion detection in blood and cerebrospinal fluid. Nat Rev Neurol 2011;7:183. [PMID: 21468111 DOI: 10.1038/nrneurol.2011.26] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Arellano-Anaya ZE, Savistchenko J, Mathey J, Huor A, Lacroux C, Andréoletti O, Vilette D. A simple, versatile and sensitive cell-based assay for prions from various species. PLoS One 2011;6:e20563. [PMID: 21655184 DOI: 10.1371/journal.pone.0020563] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
106 Orrú CD, Wilham JM, Raymond LD, Kuhn F, Schroeder B, Raeber AJ, Caughey B. Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. mBio 2011;2:e00078-11. [PMID: 21558432 DOI: 10.1128/mBio.00078-11] [Cited by in Crossref: 89] [Cited by in F6Publishing: 110] [Article Influence: 8.1] [Reference Citation Analysis]
107 Breuil J. Le diagnostic de Creutzfeldt-Jakob bientôt au fond du tube. Option/Bio 2011;22:6. [DOI: 10.1016/s0992-5945(11)70719-x] [Reference Citation Analysis]
108 Pozzetto B, Garraud O. [Emergent viral threats in blood transfusion]. Transfus Clin Biol 2011;18:174-83. [PMID: 21414828 DOI: 10.1016/j.tracli.2011.01.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
109 Talan J. Blood Test Found Specific for vCJD. Neurology Today 2011;11:1. [DOI: 10.1097/01.nt.0000395571.71877.85] [Reference Citation Analysis]
110 Khardori N. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Yearbook of Medicine 2011;2011:89-91. [DOI: 10.1016/j.ymed.2011.08.025] [Reference Citation Analysis]